Skip to content

PROCALCITONIN AND D-DIMER LEVELS: MARKERS FOR EARLY DIAGNOSIS OF ACUTE PYELONEPHRITIS IN CHILDREN WITH URINARY TRACT INFECTION

PROCALCITONIN AND D-DIMER: MARKERS FOR EARLY DIAGNOSIS OF ACUTE PYELONEPHRITIS IN CHILDREN WITH URINARY TRACT INFECTION AT TERTIARY CARE HOSPITAL - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/05/067307
Enrollment
49
Registered
2024-05-14
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N39- Other disorders of urinary system

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Jawaharlal Nehru Medical College KLE University Belagavi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children from one to eighteen years of age with symptoms of urinary tract infection 2. Positive urine routine as defined as more than or equal to 8 pus cell per cubic millimeter in clean catch, midstream urine.

Exclusion criteria

Exclusion criteria: Prior treatment with antibiotics

Design outcomes

Primary

MeasureTime frame
To study that procalcitonin and d-dimer levels are elevated in children having acute pyelonephritis in comparison with children having cystitisTimepoint: This study will be conducted over a span of one year

Secondary

MeasureTime frame
To determine the accuracy of procalcitonin & d dimer by correlating its raised levels with urine routine positivityTimepoint: This study will be conducted over a span of one year;To evaluate the ability of serum procalcitonin & d dimer to predict pyelonephritic changes as assessed by USG KUBTimepoint: This study will be conducted over a span of one year

Countries

India

Contacts

Public ContactDr Saumya Arun Verma

Jawaharlal Nehru Medical College, KLE University

patilmv1@gmail.com9483561674

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026